231 related articles for article (PubMed ID: 29385322)
1. SOX10/keratin dual-color immunohistochemistry: An effective first-line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens.
Mito JK; Conner JR; Hornick JL; Cibas ES; Qian X
Cancer Cytopathol; 2018 Mar; 126(3):179-189. PubMed ID: 29385322
[TBL] [Abstract][Full Text] [Related]
2. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
Conner JR; Cibas ES; Hornick JL; Qian X
Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
[TBL] [Abstract][Full Text] [Related]
3. Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears.
Clevenger J; Joseph C; Dawlett M; Guo M; Gong Y
Cancer Cytopathol; 2014 Oct; 122(10):779-85. PubMed ID: 24954720
[TBL] [Abstract][Full Text] [Related]
4. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
[TBL] [Abstract][Full Text] [Related]
5. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
Palla B; Su A; Binder S; Dry S
Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581
[TBL] [Abstract][Full Text] [Related]
6. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
7. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
[TBL] [Abstract][Full Text] [Related]
8. Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors.
Miettinen M; McCue PA; Sarlomo-Rikala M; Biernat W; Czapiewski P; Kopczynski J; Thompson LD; Lasota J; Wang Z; Fetsch JF
Am J Surg Pathol; 2015 Jun; 39(6):826-35. PubMed ID: 25724000
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples.
Ronchi A; Zito Marino F; Toni G; Pagliuca F; Russo D; Signoriello G; Moscarella E; Brancaccio G; Argenziano G; Franco R; Cozzolino I
J Clin Pathol; 2022 Jan; 75(1):45-49. PubMed ID: 33509946
[TBL] [Abstract][Full Text] [Related]
10. SOX10 expression in superficial spreading and nodular malignant melanomas.
Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
[TBL] [Abstract][Full Text] [Related]
11. SOX10 expression in mammary invasive ductal carcinomas and benign breast tissue.
Chiu K; Ionescu DN; Hayes M
Virchows Arch; 2019 Jun; 474(6):667-672. PubMed ID: 30903273
[TBL] [Abstract][Full Text] [Related]
12. A machine learning algorithm for simulating immunohistochemistry: development of SOX10 virtual IHC and evaluation on primarily melanocytic neoplasms.
Jackson CR; Sriharan A; Vaickus LJ
Mod Pathol; 2020 Sep; 33(9):1638-1648. PubMed ID: 32238879
[TBL] [Abstract][Full Text] [Related]
13. Sox10 and S100 in the diagnosis of soft-tissue neoplasms.
Karamchandani JR; Nielsen TO; van de Rijn M; West RB
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):445-50. PubMed ID: 22495377
[TBL] [Abstract][Full Text] [Related]
14. Dual Immunostaining With SOX10 and AE1/AE3 to Confirm Perineural Invasion on Mohs Sections.
Donaldson MR; Weber A
J Drugs Dermatol; 2019 Mar; 18(3):262-264. PubMed ID: 30909330
[TBL] [Abstract][Full Text] [Related]
15. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
[TBL] [Abstract][Full Text] [Related]
16. Utility of Sry-Related HMG-Box Gene 10 (SOX10) as a marker of melanoma in effusion cytology.
Dermawan JKT; Underwood D; Policarpio-Nicolas ML
Diagn Cytopathol; 2019 Jul; 47(7):653-658. PubMed ID: 30794352
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining patterns of alpha-keratins in normal tissues from two reptile species: implications for characterization of squamous cell carcinomas.
Orós J; López-Yánez M; Rodríguez F; Calabuig P; Castro PL
BMC Vet Res; 2018 Jul; 14(1):219. PubMed ID: 29980226
[TBL] [Abstract][Full Text] [Related]
18. Microphthalmia transcription factor immunohistochemistry for FNA biopsy of ocular malignant melanoma.
Perrino CM; Wang JF; Collins BT
Cancer Cytopathol; 2015 Jul; 123(7):394-400. PubMed ID: 25711993
[TBL] [Abstract][Full Text] [Related]
19. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical spectrum of malignant melanoma. The common presence of keratins.
Miettinen M; Franssila K
Lab Invest; 1989 Dec; 61(6):623-8. PubMed ID: 2481151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
